Predicate |
Object |
contentType |
Journal Article|Research Support, N.I.H., Extramural|Research Support, U.S. Gov't, P.H.S. |
endingPage |
4535 |
issn |
1550-6606 0022-1767 |
issueIdentifier |
7 |
pageRange |
4528-4535 |
publicationName |
Journal of immunology (Baltimore, Md. : 1950) |
startingPage |
4528 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cc5e4f38244b5316d62975d99bd14f5b |
bibliographicCitation |
Krych-Goldberg M, Hauhart RE, Porzukowiak T, Atkinson JP. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J Immunol. 2005 Oct 01;175(7):4528–35. doi: 10.4049/jimmunol.175.7.4528. PMID: 16177096. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dca47a4b59fe28976b3a61ee1b990e05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a16b0e76f1724a0e6ba34974dc48efd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8151421a1c02cd131198e6a9fdb7d148 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4ac884b88b63699677324357d716ae1 |
date |
2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/16177096 https://doi.org/10.4049/jimmunol.175.7.4528 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4816 https://portal.issn.org/resource/ISSN/1550-6606 https://portal.issn.org/resource/ISSN/0022-1767 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Synergy between Two Active Sites of Human Complement Receptor Type 1 (CD35) in Complement Regulation: Implications for the Structure of the Classical Pathway C3 Convertase and Generation of More Potent Inhibitors |
discusses |
http://id.nlm.nih.gov/mesh/M0476514 http://id.nlm.nih.gov/mesh/M0026497 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0028328 http://id.nlm.nih.gov/mesh/M0009451 http://id.nlm.nih.gov/mesh/M0004932 http://id.nlm.nih.gov/mesh/M0004921 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D003171Q000235 http://id.nlm.nih.gov/mesh/D003169Q000378 http://id.nlm.nih.gov/mesh/D050577Q000502 http://id.nlm.nih.gov/mesh/D050577Q000737 http://id.nlm.nih.gov/mesh/D017463Q000502 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D001665 http://id.nlm.nih.gov/mesh/D017434 http://id.nlm.nih.gov/mesh/D050577Q000037 http://id.nlm.nih.gov/mesh/D003169Q000737 http://id.nlm.nih.gov/mesh/D005998Q000235 http://id.nlm.nih.gov/mesh/D010649Q000378 http://id.nlm.nih.gov/mesh/D017463Q000378 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D018958Q000502 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003179Q000378 http://id.nlm.nih.gov/mesh/D005998Q000378 http://id.nlm.nih.gov/mesh/D017463Q000235 http://id.nlm.nih.gov/mesh/D010649Q000235 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cff6c29e8e17f792e800f07b0ad5dc89 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.47 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0a3d72134fb3d6c024db4c510bc1605b |